购物车
- 全部删除
- 您的购物车当前为空
NTP42 是血栓素 A2 (TXA2) 受体的拮抗剂,IC50为 3.278 nM,可用于肺动脉高压的相关研究。
为众多的药物研发团队赋能,
让新药发现更简单!
NTP42 是血栓素 A2 (TXA2) 受体的拮抗剂,IC50为 3.278 nM,可用于肺动脉高压的相关研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 296 | 现货 | |
5 mg | ¥ 696 | 现货 | |
10 mg | ¥ 1,090 | 现货 | |
25 mg | ¥ 1,930 | 现货 | |
50 mg | ¥ 2,850 | 现货 | |
100 mg | ¥ 3,970 | 现货 | |
200 mg | ¥ 5,520 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 773 | 现货 |
产品描述 | NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM) |
体内活性 | From haemodynamic assessments, NTP42 reduced the MCT-induced PAH, including mean pulmonary arterial pressure (mPAP) and right systolic ventricular pressure (RSVP), being at least comparable to the standard-of-care drugs Sildenafil or Selexipag in bringing about these effects.?Moreover, NTP42 was superior to Sildenafil and Selexipag in significantly reducing pulmonary vascular remodelling, inflammatory mast cell infiltration and fibrosis in MCT-treated animals[1]. |
分子量 | 515.53 |
分子式 | C25H23F2N3O5S |
CAS No. | 2055599-51-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 30 mg/mL (58.19 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.